In summary, we demonstrated that atorvastatin prevents development of hepatic steatosis, inflammation and fibrosis in APOE*3-Leiden mice, a model that develops atherosclerosis and NASH upon WTD-feeding. The gene discussed is APOE; the disease is metabolic dysfunction-associated steatohepatitis.